Neurogene Inc. (NASDAQ: NGNE)
$45.74
-0.2100 ( -0.46% ) 90.0K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$45.74
Previous close
$45.95
Volume
90.0K
Market cap
$593.85M
Day range
$44.25 - $47.31
52 week range
$12.49 - $53.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Mar 14, 2024 |
| 4 | Insider transactions | 1 | Mar 14, 2024 |
| 8-k | 8K-related | 52 | Mar 04, 2024 |
| 8-k | 8K-related | 14 | Feb 21, 2024 |
| 4 | Insider transactions | 1 | Jan 18, 2024 |
| 3 | Insider transactions | 2 | Jan 18, 2024 |
| 4 | Insider transactions | 1 | Jan 18, 2024 |
| 4 | Insider transactions | 2 | Jan 18, 2024 |
| 4 | Insider transactions | 1 | Jan 18, 2024 |
| 4 | Insider transactions | 2 | Jan 18, 2024 |